Company: NCEL
Filing Date: 2025-09-10
Form Type: 424B3
Source: 0001213900-25-086600
Chunk: 460

Company: NewcelX Ltd.
Filing Date: 2025-09-10
Form: 424B3
Chunk 460
---
1,145,575 for the year ended December31, 2023. The decrease is primarily due to the receipt of $1.7million under a convertible loan agreement between Kadimastem and its shareholders, Alpha and Mr.Julien Ruggieri, of which $1.25million was received on December21, 2023, and $450,000 was received on April20, 2024. The balance of cash and cash equivalents for the year ended December31, 2023, was $1,145,575, representing a decrease of $670,850 (37%), compared to $1,816,425 for the year ended December31, 2022. The decrease is primarily due to the net use of cash for operating activities. Net Cash Used in Operating Activities Net cash used in operating activities for the year ended December31, 2024, was $705,483 representing a decrease of $2,290,330 compared to $2,995,813 for the year ended December31, 2023. This decrease was mainly due to the reduction in general and administrative expenses and Kadimastem’s efficiency measures during the reporting period which included a reduction in research and development expenses. Net cash used in operating activities for the year ended December31, 2023, was $3,004,813 representing a decrease of $2,950,385 (49.5%), compared to $5,955,198 for the year ended December31, 2022. This decrease was mainly due to the reduction in general and administrative expenses and Kadimastem’s efficiency measures during the reporting period which included a reduction in research and development expenses. Net Cash Used in Investing Activities Net cash received in investing activities for the year ended December31, 2024, was $161,394, reflecting an increase of $70,844 compared to cash used of $90,550 for the year ended December31, 2023. The change was mainly attributed to purchases of fixed assets and changes in pledged cash. Net cash received in investing activities for the year ended December31, 2023, was $90,250, reflecting an increase of $105,120 (53.8%), compared to cash used of $195,370 for the year ended December31, 2022. The change was mainly attributed to changes in bank deposits during the year ended December31, 2023. Net Cash Provided by Financing Activities Over the period 2021 to 2024, Kadimast